Aging, neuroendocrine function, and osteoporosis

Experimental Gerontology

Volumn 32, Issue 4-5, 1997, Pages 577-586

  Peterlik, Meinrad ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Dept of Gen and Exp Pathology ^*  (Austria)

Author keywords

Bone remodeling; Hormones; Neuroendocrine regulation; Neuropeptides; Neurotransmitters; Skeletal system

Indexed keywords

NEUROPEPTIDE;

AGING; BONE REMODELING; CONFERENCE PAPER; HORMONAL REGULATION; HUMAN; NEUROENDOCRINOLOGY; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

AGING; ANIMALS; BONE REMODELING; ENDOCRINE SYSTEM DISEASES; HUMANS; NEUROSECRETORY SYSTEMS; OSTEOPOROSIS;

EID: 0030748812     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(96)00160-X     Document Type: Conference Paper

References (61)

1. ARMBRECHT, H.J. Effect of age on calcium and phosphate absorption. Role of 1,25-dihydroxyvitamin D. Miner. Electrolyte Metab. 16, 159-166, 1990.
2. 1(I)-procollagen and transforming growth factor-β steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 128, 2723-2730, 1991.
3. BJURHOLM, A., KREICBERGS, A., BRODIN, E., and SCHULTZBERG, M. Substance P- and CGRP-immunoreactive nerves in bone. Peptides 9, 165-171, 1988.
4. BJURHOLM, A. Neuroendocrine peptides in bone. Thesis, Gotab, Stockholm 1989.
5. BJURHOLM, A. Neuroendocrine peptides in bone. Int. Orthop. 15, 325-329, 1991.
6. BJURHOLM, A., KREICBERGS, A., SCHULTZBERG, M., and LERNER, U.H. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J. Bone Miner. Res. 7, 1011-1119, 1992.
7. BRONNER, F. Calcium and osteoporosis. Am. J. Clin. Nutr. 60, 831-836, 1994.
8. CANALIS, E. Regulation of bone remodeling. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Favus, M.J. (Editor), pp. 33-37, Raven Press, New York, 1993.
9. CANO, R.P., MONZOYA, M.J., MORUNO, R., VAZQUEZ, A., GALAN, F., and GARRIDO, M. Calcitonin reserve in healthy women and patients with postmenopausal osteoporosis. Calcif. Tissue Int. 45, 203-208, 1989.
10. CHAPUY, M.C., ARLOT, M.E., DUBOEUF, F., BRUN, J., CROUZET, B., ARNAUD, S., DELMAS, P.J., and MEUNIER, P.J. Vitamin D3 and calcium to prevent hip fractures in the elderly. N. Engl. J. Med. 327, 1637-1642, 1992.
11. COPP, D.H. Calcitonin comparative endocrinology. In: Endocrinology, Vol. 2, Degroot, L. (Editor) pp. 637-645, Grune and Stratton, New York, 1979.
12. CROSS, H.S., KLAUSHOFER, K., and PETERLIK, M. Triiodothyronine and 1,25-dihydroxyvitamin D3: Actions and interactions at the gene, cell and organ level. In: Extra- and Intracellular Calcium and Phosphate Regulation: From Basic Research to Clinical Medicine, Bronner, F. and Peterlik, M. (Editors), pp. 93-109, CRC Press, Boca Raton, FL, 1992.
13. DEGERBLAD, M., ELGINDY, N., HALL, K., SJOBERG, H.-E., and THOREN, M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol. 126, 387-393, 1992.
14. EBELING, P.R., YERGEY, A.L., VIEIRA, N.E., BURRITT, M.F., O'FALLON, W.M., KUMAR, R., and RIGGS, B.L. Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women. Calcif. Tissue Int. 55, 330-334, 1994.
15. ERIKSEN, E.F., COLVARD, D.S., BERG, N.J., GRAHAM, M.L., MANN, K.G., SPELSBERG, T.C., and RIGGS, B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241, 84-86, 1988.
16. ERIKSEN, E.F., AXELROD, D.W., and MELSEN, F. Bone remodeling in metabolic bone disease. In: Bone Histomorphometry, pp. 51-59, Raven Press, New York, 1994.
17. ERNST, M., SCHMID, C., and FROESCH, E.R. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc. Natl. Acad. Sci. USA 85, 2307-2310, 1988.
18. FROST, H.M. Vital biomechanics: Proposed general concepts for skeletal adaptation to mechanical usage. Calcif. Tissue Int. 42, 145-156, 1988.
19. GALLAGHER, J.C., RIGGS, B.L., EISMAN, J., HAMSTRA, A., ARNAUD, S.B., and DELUCA, H.F. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J. Clin. Invest. 64, 729-736, 1979.
20. GIRASOLE, G., PASSERI, G., JILKA, R.L., and MANOLAGAS, S.C. Interleukin 11: A new cytokine critical for osteoclast development. J. Clin. Invest. 93, 1516-1524, 1994.
21. GOWEN, M., WOOD, P.D., IHRIE, E.T., MCQUIRE, M.K.B., and RUSSELL, R.G.G. An interleukin 1-like factor stimulates bone resorption in vitro. Nature 306, 378-380, 1983.
22. HILL, E.L. and ELDE, R. Calcitonin gene-related peptide-immunoreactive nerve fibers in mandibular periosteum of rat: Evidence for primary afferent origin. Neurosci. Lett. 85, 172-178, 1988.
23. HILL, E.L. and ELDE, R. Distribution of CGRP-, VIP-, D-β-H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res. 264, 469-480, 1991.
24. HILL, E.L., TURNER, R., andELDE, R. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience 44, 747-755, 1991.
25. HOHMANN, E.L., ELDE, R.P., RYSAVY, J.A., EINZIG, S., and GEBHARD, R.L. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 232, 868-871, 1986.
26. HUKKANEN, M., KONTTINEN, Y.T., RESS, R.G., SANTAVIRTA, S., TERENGHI, G., and POLAK, J.M. Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int. J. Tissue React. 14, 1-10, 1992.
27. IRANMANESH, A. and VELDHUIS, J.D. Clinical pathophysiology of the somatotropic (GH) axis in adults. In: Endocrinology and Metabolism Clinics of North America, Veldhuis, J.D. (Editor), pp. 783-816, W.B. Saunders, Philadelphia, 1992.
28. IRELAND, P. and FORDTRAN, J.S. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J. Clin. Invest. 52, 2672-2681, 1973.
29. JILKA, R.L., HANGOC, G., GIRASOLE, G., PASSERI, G., WILLIAMS, D., ABRAMS, J., BROXMEYER, H., and MANOLAGAS, S.C. Increased osteoclast development after estrogen loss: mediation by interleukin 6, Science 257, 88-91, 1992.
30. KANIS, J.A. Osteoporosis, Blackwell Science, Oxford 1994.
31. KLAUSHOFER, K., HOFFMANN, O., GLEISPACH, H., LEIS, H.J., LUGER, T., KOLLER, K., and PETERLIK, M. Bone resorbing activity of thyroid hormones is related to prostaglandin production in neonatal mouse calvaria. J. Bone Miner. Res. 4, 305-312, 1989a.
32. KLAUSHOFER, K., HÖRANDNER, H., HOFFMANN, O., CZERWENKA, E., KONIG, U., KOLLER, K., and PETERLIK, M. Interferon-γ and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria. J. Bone Min. Res. 4, 585-606, 1989b.
33. KLAUSHOFER, K., VARGA, F., GLANTSCHNIG, H., FRATZL-ZELMAN, N., CZERWENKA, E., LEIS, H.J., KOLLER, K., and PETERLIK, M. The regulatory role of thyroid hormones in bone cell growth and differentiation. J. Nutr. 125, 1996S-2003S, 1995.
34. KLAUSHOFER, K. and PETERLIK, M. Pathophysiology of osteoporosis. In: Osteoporosis: A Guide to Diagnosis and Treatment, Bröll, H. and Dambacher, M. (Editors), pp. 12-27, Karger, Basel, 1996.
35. KOMM, B.S., TERPENING, C.M., BENZ, D.J., GRAEME, K.A., GALLEGOS, A., KORC, M., GREENE, G.L., OMALLEY, B.W., and HAUSSLER, M.R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241, 81-84, 1988.
36. MARCUS, R. Skeletal aging. Understanding the functional and structural basis of osteoporosis. Trends Endocrinol. Metab. 2, 53-58, 1991.
37. 2 stimulates insulin-like growth factor 1 synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 128, 2895-2900, 1991.
38. MCSHEEHY, P.M.J. and CHAMBERS, T.J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118, 824-828, 1986.
39. MELTON, L.J. and RIGGS, B.L. Clinical spectrum. In: Osteoporosis. Etiology, Diagnosis, and Management, Riggs B.L. and Melton L.J. (Editors), pp. 155-179, Raven Press, New York, 1988.
40. MORRISON, N.A., QI, J.C., TOKITA, A., KELLY, P.J., CROFTS, L., NGUYEN, T.V., SAMBROOK, P.N., and EISMAN, J.A. Prediction of bone density from vitamin D receptor alleles. Nature 367, 284-287, 1994.
41. MOORADIAN, A.D. and WONG, N.C.W. Age-related changes in thyroid hormone action. Eur. J. Endocrinol. 131, 451-461, 1994.
42. OIKARINEN, A.I., UITTO, J., and OIKARINEN, J. Glucocorticoid action on connective tissue: From molecular mechanisms to clinical practice. Med. Biol. 64, 221-230, 1986.
43. OURSLER, M.J., OSDOBY, P., PYFFEROEN, J., RIGGS, L.B., and SPELSBERG, T.C. Avian osteoclasts as estrogen target cells. Proc. Natl. Acad. Sci. USA 66, 6613-6617, 1991.
44. PACIFICI, R., RIFAS, L., TEITELBAUM, S., SLATOPOLSKY, E., MCCRACKEN, R., BERGFELD, M., LEE, W., AVIOLI, L.V., and PECK, W.A. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc. Natl. Acad. Sci. USA 84, 4616-4620, 1987.
45. PETERLIK, M., HOFFMANN, O., SWETLY, P., KLAUSHOFER, K., and KOLLER, K. Recombinant γ-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria. FEBS Lett. 185, 287-290, 1985.
46. POCKWINSE, S.M., STEIN, J.L., LIAN, J.B., and STEIN, G.S. Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: Interrelationship of morphology and gene expression by in situ hybridization. Exp. Cell Res. 216, 244-260, 1995.
47. RAISZ, L.G. Local and systemic factors in the pathogenesis of osteoporosis. N. Engl. J. Med. 318, 818-828, 1988.
48. RAISZ, L.G. The role of prostaglandins in the local regulation of bone metabolism. In: Molecular and Cellular Regulation of Calcium and Phosphate Metabolism, Peterlik, M. and Bronner, F. (Editors), pp. 195-203, Wiley-Liss, New York, 1990.
49. RIGBY, W.F.C. The immunobiology of vitamin D. Immunol. Today 9, 54-58, 1988.
50. ROBEY, P.G., FISHER, L.W., YOUNG, M.F., and TERMINE, J.D. The biochemistry of bone. In: Osteoporosis: Etiology, Diagnosis, and Management, Riggs L.B. and Melton L.J. (Editors), pp. 95-109, Raven Press, New York, 1988.
51. RODAN, G.A. and MARTIN, T.J. Role of osteoblasts in hormonal control of bone resorption - A hypothesis. Calcif. Tissue Int. 33, 349-351, 1981.
52. ROSEN, H. and BAR-SHAVIT, Z. Dual role of osteoblastic proenkephalin derived peptides in skeletal tissues. J. Cell. Biochem. 55, 334-339, 1994.
53. SCHILLER, C., REDLICH, K., PIETSCHMANN, P., and PETERLIK, M. Multihormonal effects on osteoclast formation: role of IL-6. Bone 16, 401, 1995.
54. SEEMAN, E., HOPPER, J.L., BACH, L.A., COOPER, M.E., PARKINSON, E., MCKAY, J., and JERUMS, G. Reduced bone mass in daughters of women with osteoporosis. N. Engl. J. Med. 320, 554-558, 1989.
55. SHERMAN, B.E. and CHOLE, R.A. A mechanism for sympathectomy-induced bone resorption in the middle ear. Otolaryngol. Head Neck Surg. 113, 569-581, 1995.
56. STEIN, G.S., LIAN, J.B., and OWEN, T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4, 3111-3123, 1990.
57. STUMPF, W.E. Vitamin D - Soltriol. The heliogenic steroid hormone: Somatotrophic activator and modulator. Histochemistry 89, 209-219, 1988.
58. TAM, C.S., HEERSCHE, J.N.M., MURRAY, T.M., and PARSONS, J.A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110, 506-512, 1982.
59. VAES, G. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin. Orthop. Rel. Res. 231, 239-271, 1988.
60. WATANABE, K., TANAKA, Y., MORIMOTO, I., YAHATA, K., ZEKI, K., FUJIHIRA, T., YAMASHITA, U., and ETO, S. Interleukin-4 as a potent inhibitor of bone resorption. Biochem. Biophys. Res. Comm. 172, 1035-1041, 1990.
61. ZAIDI, M., CHAMBERS, T.J., BELVIS, B.J., BEACHAM, J.L., GAINES-DAS, R.E., and MCINTYRE, I. Effects of peptides from the calcitonin genes on bone and bone cells. Qt. J. Exp. Physiol. 73, 471-485, 1988.